Business

July 22, 2014 10:28 AM

Cancer Genetics completes $6.25M acquisition of Morrisville-based Gentris

Cancer Genetics, a publicly-traded New Jersey company, has completed its $6.25 million acquisition of Morrisville-based pharmacogenomics business Gentris Corp.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs